Hillenbrand Inc. has announced the sale of a 51% stake in its Milacron injection molding and extrusion business to an ...
Hillenbrand (NYSE: HI), Milacron’s current owner, will continue to remain a significant investor in the business. BOSTON & BATESVILLE, Ind.--(BUSINESS WIRE)--Bain Capital, a leading private investment ...
An affiliate of Bain Capital will acquire 51 per cent of the injection molding and extrusion machinery maker from current owner Hillenbrand Inc.
According to the terms of the deal, Bain has agreed to acquire a 51 percent stake in Milacron for $287 million.
On February 5, the company entered into a definitive agreement to sell an ownership stake of approximately 51% in its Milacron injection ...
Key alts deals unveiled today include Silver Point's $250 million CLO fund close, Bain Capital's stake in manufacturer Milacron, a KKR-backed tech acquisition.
Hillenbrand Inc. has announced plans to sell a 51 percent stake in its Cincinnati-based subsidiary Milacron LLC, to an affiliate of Boston-based investment firm Bain Capital. Hillenbrand, which is ...
Taking a look at a Graham Partners-backed technology company that is pursuing a continuation vehicle funding after running a ...
13h
Hosted on MSNBain Capital buys Mitsubishi Tanabe Pharma for $3.3bnBain said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare industry.
The Japanese chemical company has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a ...
Hillenbrand Inc. has announced the sale of a 51 percent stake in its Milacron injection molding and extrusion machinery ...
The provider of highly-engineered processing equipment and solutions will sell a 51% stake in the injection molding and extrusion business for $287 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results